Sionna Therapeutics, Inc. (SION)
3.89
-0.19
(-4.66%)
USD |
NASDAQ |
Oct 16, 16:00
3.92
+0.03
(+0.77%)
After-Hours: 20:00
Sionna Therapeutics Cash from Investing (Quarterly) : 21.47M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.47M |
| March 31, 2026 | 24.82M |
| December 31, 2025 | 22.59M |
| September 30, 2025 | 23.10M |
| June 30, 2025 | -23.24M |
| Date | Value |
|---|---|
| March 31, 2025 | -141.19M |
| December 31, 2024 | 15.23M |
| September 30, 2024 | 10.41M |
| June 30, 2024 | -28.62M |
| March 31, 2024 | -123.93M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -45.80M |
| Capricor Therapeutics, Inc. | -48.76M |
| ARS Pharmaceuticals, Inc. | 41.57M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Immunic, Inc. | -0.249M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.22M |
| Cash from Financing (Quarterly) | 0.749M |
| Free Cash Flow | -76.21M |
| Free Cash Flow Per Share (Quarterly) | -0.4921 |
| Free Cash Flow to Equity (Quarterly) | -21.91M |
| Free Cash Flow to Firm (Quarterly) | -22.22M |
| Free Cash Flow Yield | -43.68% |